Meningioma Clinical Trials in Miami, Florida

4 studies are recruiting for meningioma in Miami, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

    The objective of the study is to evaluate efficacy and safety of zanzalintinib in participants with recurrent or progressive meningioma refractory to standard therapies.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Baptist Health Miami Cancer Institute, Miami, Florida
    Locations
    17 in total
    Run by
    Exelixis

    See if you can join NCT07428616 on ClinicalTrials.gov

  2. Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

    This is a multi-arm phase II platform-basket screening study designed to test multiple experimental therapies simultaneously in patients with NF2-related schwannomatosis (NF2-SWN, formerly known as neurofibromatosis type 2) with associated progressive tumors of vestibular schwannomas (VS), non-vest…

    Stage
    Phase 2
    Ages
    12 and older
    Site
    University of Miami, Miami, Florida
    Locations
    6 in total
    Run by
    Scott R. Plotkin, MD, PhD

    See if you can join NCT04374305 on ClinicalTrials.gov

  3. Cabozantinib for Patients With Recurrent or Progressive Meningioma

    A Phase II Study of Cabozantinib for Patients with Recurrent or Progressive Meningioma

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Miami Cancer Institute at Baptist Health, Inc., Miami, Florida
    Locations
    3 in total
    Run by
    Baptist Health South Florida

    See if you can join NCT05425004 on ClinicalTrials.gov

  4. Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

    This study is Phase I/IIa First-in-Human Study of [212Pb]VMT-α-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Tumors

    Stage
    Phase 1
    Ages
    18 to 90
    Site
    Biogenix Molecular, Miami, Florida
    Locations
    19 in total
    Run by
    Perspective Therapeutics

    See if you can join NCT05636618 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.